Status:
COMPLETED
BioWare for AUD and PTSD
Lead Sponsor:
Medical University of South Carolina
Conditions:
PTSD
Alcohol Use Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for indiv...
Eligibility Criteria
Inclusion
- Male or female; aged 18-70 years.
- Able to provide written informed consent.
- Meet DSM-5 diagnostic criteria for current moderate to severe alcohol use disorder.
- Meet DSM-5 diagnostic criteria for current PTSD.
- Participants taking psychotropic medications will be required to be maintained on a stable dose for at least 4 weeks before study initiation.
Exclusion
- Meet DSM-5 criteria for a history of or current psychotic or bipolar disorders.
- Current suicidal or homicidal ideation and intent.
- Psychotropic medications which have been initiated during the past 4 weeks.
- Acute alcohol withdrawal.
- Pregnancy or breastfeeding for people of childbearing potential.
- Currently enrolled in evidence based behavioral treatment for AUD or PTSD.
- Implanted electronic devices of any kind, including pacemakers, electronic infusion pumps, stimulators, defibrillators or similar.
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2023
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT05187364
Start Date
May 5 2022
End Date
February 20 2023
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425